Education
JD/MBA Suffolk University
2009-2014
- Part-time dual-degree student with dual concentration in business and IP
- Best Brief award in legal writing
- Best Brief award in legal writing
MS Boston University
2004-2007
- Biomedical Engineering
- Thesis: Gradient Microenvironments for Neural Stem Cell Based Regenerative Materials
- Thesis: Gradient Microenvironments for Neural Stem Cell Based Regenerative Materials
BS Northeastern University
2000-2004
- Dual degree in neuroscience and economics
- Academic excellence scholarship recipient
- President of NeURoN (Northeaster University Research On Neuroscience)
- Academic excellence scholarship recipient
- President of NeURoN (Northeaster University Research On Neuroscience)
Business Experience
Vertex Pharmaceuticals
2010-Current
Manager; Strategic Finance and Decision Analytics
- Lead valuation efforts for deal team negotiations in both M&A and out- / in-licensing activities
- Influenced key leaders across Vertex by challenging status-quo and clearly delivering complex analytics
- Played lead role in the corporate portfolio management and long-range planning process
- Developed flexible portfolio optimization engine
- Build and implemented unique revenue forecasting methodology for our target markets
- Lead financial diligence efforts of all key external vendors
- Lead valuation efforts for deal team negotiations in both M&A and out- / in-licensing activities
- Influenced key leaders across Vertex by challenging status-quo and clearly delivering complex analytics
- Played lead role in the corporate portfolio management and long-range planning process
- Developed flexible portfolio optimization engine
- Build and implemented unique revenue forecasting methodology for our target markets
- Lead financial diligence efforts of all key external vendors
Codon Partners, LLC
2009-Current
Co-founder / Partner
Consulted for multiple clients including but not limited to TransForm Pharmaceuticals, JoVE, InSilicore and Human Care Systems. Projects have included revenue forecasting, organizational design, business development, analytics, primary market research, out-licensing support and MTA / NDA negotiation.
EPIX Pharmaceuticals
2007-2009
Business Development & Strategic Planning Associate
- Drafted all out-licensing presentations for business development activities
- Met with and presented company asset out-licensing presentations to executives at all levels
- Negotiated and executed MTAs & CDAs
- Organized and supported due diligence efforts from multiple partners
- Built competitive intelligence database for 11+ TAs in clinical and preclinical development
- Managed alliance with Amgen (EPIX out-licensed S1P1 program)
- Fostered and maintained relationships with key opinion leaders in each development program niche
- Performed targeted analyses (including SWOT) and research for business development opportunities
- Drafted all out-licensing presentations for business development activities
- Met with and presented company asset out-licensing presentations to executives at all levels
- Negotiated and executed MTAs & CDAs
- Organized and supported due diligence efforts from multiple partners
- Built competitive intelligence database for 11+ TAs in clinical and preclinical development
- Managed alliance with Amgen (EPIX out-licensed S1P1 program)
- Fostered and maintained relationships with key opinion leaders in each development program niche
- Performed targeted analyses (including SWOT) and research for business development opportunities
Deal Sheet
April 2011 - Cystic Fibrosis Foundation Therapeutics Development Agreement
April 2009 - $28M License of US, CA and AU rights of Vasovist to Lantheus
April 2007 - Cystic Fibrosis Foundation Therapeutics Development Agreement
April 2009 - $28M License of US, CA and AU rights of Vasovist to Lantheus
April 2007 - Cystic Fibrosis Foundation Therapeutics Development Agreement
Scientific Experience
Klapperich Lab. Boston University. Biomedical Microdevice and Microenvironments Lab
2006-2007
Developed a thermoplastic, microfluidic platform for directing neural stem cell growth on compliant and peptide gradient hydrogels
Millennium Pharmaceuticals
2005-2006
Isolated and elucidated the structure of drug metabolites in multiple stages of development/discovery including clinical trials using HPLC-MS with radio-labeled compounds
Jay Lab. Tufts Medical School. Department of Cellular and Molecular Physiology
2003-2004
Automated a proteome wide inactivation screen for anti-invasion proteins using fluorophore-assisted light inactivation (FALI) and a liquid handling robot
Melloni Lab. Northeastern University. Department of Psychology
2000-2004
Investigated the pharmacological effects of cocaine on neural systems (mainly, 5-HT3) that modulate offensive aggression in Syrian hamsters
Skills
Financial valuation, decision analytics, monte-carlo simulation, real-options, portfolio management, portfolio optimization, corporate/strategic planning, market research, VisualBasic, VBA, MATLAB, EvaluatePharma, Medtrack, Recap, CapitalIQ, IDDB & Palisade Decision Suite (@Risk, PrecisionTree, TopRank, etc)
